In 2006, the 38,000 member strong, American Psychiatric Association, received 30% of their funding, or more than $20 million, from the pharmaceutical industry.
This year's attendees at the group's annual meeting last month in New Orleans "had to brave 200 protestors chanting "no drugging kids for money" and "no conflicts of interest" to get into the convention hall," according to Martha Rosenberg's May 30, 2010 report in OpEd News.
"If there were a take home message at the APA meeting about the blizzard of ADHD, bipolar and personality disorders threatening adults and children, it was don't wait," Rosenberg says. "These dangerous conditions, likened to cancer and diabetes, won't go away."
"Thanks to genetic advancements, psychiatric disease risks can now be detected and treated before symptoms surface, said presenters, fostering early treatment paradigms that are pretty Brave New World: People being told they have a disease they can't feel that needs immediate and lifelong treatment at hundreds of dollars a month or their health will suffer," she reports.
"Preemptive psychiatric drugging is likely the most dangerous idea that has come along since lobotomy," warns the prolific anti-drugging activist, Vince Boehm.
As far as drugs, there was no star of the show, Rosenberg says. "The Next Big Thing was not a new drug at all but adjunctive therapy also known as adding existing drugs to existing drugs because they don't work right."
"Throwing good drugs after bad, popularized with the antipsychotic Abilify," she explains, "has only been enhanced by a study in the January JAMA that found antidepressants don't work for mild depression at all."
Next Page 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).